These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Expression of Human Papillomavirus and the p16 Gene in Oral Potentially Malignant Disorders (OPMD): a Comparative Study With Oral Squamous Cell Carcinoma. Baddevithana AK; Jayasinghe RD; Tilakaratne WM; Illeperuma RP; Siriwardena BSMS Appl Immunohistochem Mol Morphol; 2023 May-Jun 01; 31(5):331-338. PubMed ID: 37036407 [TBL] [Abstract][Full Text] [Related]
3. American Association of Oral and Maxillofacial Surgeon's Position Paper on Oral Mucosal Dysplasia. Carlson ER; Kademani D; Ward BB; Oreadi D J Oral Maxillofac Surg; 2023 Aug; 81(8):1042-1054. PubMed ID: 37244288 [TBL] [Abstract][Full Text] [Related]
4. Cancer Stem Cell Markers, CD44 and ALDH1, for Assessment of Cancer Risk in OPMDs and Lymph Node Metastasis in Oral Squamous Cell Carcinoma. Dhumal SN; Choudhari SK; Patankar S; Ghule SS; Jadhav YB; Masne S Head Neck Pathol; 2022 Jun; 16(2):453-465. PubMed ID: 34655409 [TBL] [Abstract][Full Text] [Related]
5. Oral potentially malignant disorders: A consensus report from an international seminar on nomenclature and classification, convened by the WHO Collaborating Centre for Oral Cancer. Warnakulasuriya S; Kujan O; Aguirre-Urizar JM; Bagan JV; González-Moles MÁ; Kerr AR; Lodi G; Mello FW; Monteiro L; Ogden GR; Sloan P; Johnson NW Oral Dis; 2021 Nov; 27(8):1862-1880. PubMed ID: 33128420 [TBL] [Abstract][Full Text] [Related]
6. Evaluation and Management of Oral Potentially Malignant Disorders. Nadeau C; Kerr AR Dent Clin North Am; 2018 Jan; 62(1):1-27. PubMed ID: 29126487 [TBL] [Abstract][Full Text] [Related]
7. Prevalence and factors associated with oral potentially malignant disorders and oral squamous cell carcinoma: An institutional study. Shah JS; Dubey J J Cancer Res Ther; 2023 Jan; 19(Suppl 2):S536-S544. PubMed ID: 38384016 [TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical Expression of Epidermal Growth Factor Receptor (EGFR) in Oral Squamous Cell Carcinoma and Oral Potentially Malignant Disorders. Aamir R; Rauf F; Iqbal F; Yousuf S; Rehman A; Sheikh AK; Muhammad S Appl Immunohistochem Mol Morphol; 2024 Mar; 32(3):157-162. PubMed ID: 38268382 [TBL] [Abstract][Full Text] [Related]
9. Oral potentially malignant disorders: A comprehensive review on clinical aspects and management. Warnakulasuriya S Oral Oncol; 2020 Mar; 102():104550. PubMed ID: 31981993 [TBL] [Abstract][Full Text] [Related]
10. ICI-based therapies: A new strategy for oral potentially malignant disorders. Wang T; Sun S; Zeng X; Li J Oral Oncol; 2023 May; 140():106388. PubMed ID: 37054586 [TBL] [Abstract][Full Text] [Related]
11. Developmental synergism in the management of oral potentially malignant disorders. Tan YQ; Li ZT; Zhou G Photodiagnosis Photodyn Ther; 2023 Jun; 42():103563. PubMed ID: 37031901 [TBL] [Abstract][Full Text] [Related]
12. Malignant transformation in 5071 southern Taiwanese patients with potentially malignant oral mucosal disorders. Wang YY; Tail YH; Wang WC; Chen CY; Kao YH; Chen YK; Chen CH BMC Oral Health; 2014 Aug; 14():99. PubMed ID: 25096230 [TBL] [Abstract][Full Text] [Related]
13. Assessment of serum synuclein-γ and squamous cell carcinoma antigen as diagnostic biomarkers in patients with oral squamous cell carcinoma and oral potentially malignant disorders. Chen L; Luo T; Yang J; Wang K; Liu S; Wei Y; Liu H; Xu J; Zheng J; Zeng Y J Oral Pathol Med; 2021 Feb; 50(2):165-174. PubMed ID: 33064859 [TBL] [Abstract][Full Text] [Related]
14. [Update on current care guidelines: oral cancer]. Duodecim; 2012; 128(7):770-1. PubMed ID: 22612027 [TBL] [Abstract][Full Text] [Related]
15. Extracellular Vesicles in Oral Squamous Cell Carcinoma and Oral Potentially Malignant Disorders: A Systematic Review. Yap T; Pruthi N; Seers C; Belobrov S; McCullough M; Celentano A Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32054041 [TBL] [Abstract][Full Text] [Related]
16. Dentists' Perception of Oral Potentially Malignant Disorders. Tarakji B Int Dent J; 2022 Jun; 72(3):414-419. PubMed ID: 35227496 [TBL] [Abstract][Full Text] [Related]
17. Revisiting the evidence of photodynamic therapy for oral potentially malignant disorders and oral squamous cell carcinoma: An overview of systematic reviews. Schuch LF; Schmidt TR; Kirschnick LB; de Arruda JAA; Campagnol D; Martins MAT; Santos-Silva AR; Lopes MA; Vargas PA; Bagnato VS; Kurachi C; Guerra ENS; Martins MD Photodiagnosis Photodyn Ther; 2023 Jun; 42():103531. PubMed ID: 36963644 [TBL] [Abstract][Full Text] [Related]
18. History and future perspectives for the use of fluorescence visualization to detect oral squamous cell carcinoma and oral potentially malignant disorders. Tomo S; Miyahara GI; Simonato LE Photodiagnosis Photodyn Ther; 2019 Dec; 28():308-317. PubMed ID: 31600576 [TBL] [Abstract][Full Text] [Related]
19. [Current concepts in diagnosis and treatment of oral malignant tumors]. Hullmann MM; Reichert TE Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2011 Sep; 54(9):1083-8. PubMed ID: 21887623 [TBL] [Abstract][Full Text] [Related]
20. A novel 4-gene signature model simultaneously predicting malignant risk of oral potentially malignant disorders and oral squamous cell carcinoma prognosis. Zhang X; Yang M; Liu Y; Liu H; Yang J; Luo J; Zhou H Arch Oral Biol; 2021 Sep; 129():105203. PubMed ID: 34252587 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]